VP of Worldwide Sales and Marketing · IRADIMED CORP (IRMD)

Randy Waddell

A named executive officer of IRADIMED in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$597,277

Salary $262,038Stock awards $151,126

FY2022: $560,022

3rd of 3 named executive officers at Iradimed by FY2023 total.

3 named officers on file for IRADIMED, FY2023

Randy Waddell’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IRADIMED’s whole pay program stands against its peers

  • IRADIMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Randy Waddell’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Randy Waddell compensation by year

IRADIMED Summary Compensation Table · all 2 fiscal years held
In US dollars, as IRADIMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$247,558$262,038
Bonus$0$0
Stock awards$145,393$151,126
Option awards$0$0
Non-equity incentive$130,217$141,733
Pension and deferred compensation$0$0
All other$36,854$42,380
Total$560,022$597,277

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IRADIMED CORP DEF 14A filed April 29, 2024, accession 0001558370-24-006105, and prior-year filings.

How this page was built: the IRADIMED CORP filed document, accession 0001558370-24-006105. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$560K
$597K
FY22
FY23
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU3,710$171,439—
RSU2,139$98,843—
RSU1,530$70,701—
RSU1,295$59,842—
RSU1,294$59,796—
RSU1,239$57,254—
RSU443$20,471—

Per the Outstanding Equity Awards at Fiscal Year-End table in IRADIMED CORP's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

IRADIMED’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
John GlennChief Financial Officer$1,267,324
Roger SusiPresident and Chief Executive Officer$642,566
Randy Waddell · this pageVP of Worldwide Sales and Marketing$597,277

The full IRADIMED compensation record

free company brief

This page is one person within IRADIMED's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IRADIMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Randy Waddell's compensation dossier · One-time report. No refunds.